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AbdB-like HOX proteins form DNA-binding complexes with the TALE superclass proteins MEIS1A and MEIS1B, and trimeric
complexes have been identified in nuclear extracts that include a second TALE protein, PBX. Thus, soluble DNA-independent protein–
protein complexes exist in mammals. The extent of HOX/TALE superclass interactions, protein structural requirements, and sites of in vivo
cooperative interaction have not been fully explored. We show that Hoxa13 and Hoxd13 expression does not overlap with that of Meis1–3 in
the developing limb; however, coexpression occurs in the developing male and female reproductive tracts (FRTs). We demonstrate that both
HOXA13 and HOXD13 associate with MEIS1B in mammalian and yeast cells, and that HOXA13 can interact with all MEIS proteins but not
more diverged TALE superclass members. In addition, the C-terminal domains (CTDs) of MEIS1A (18 amino acids) and MEIS1B (93 amino
acids) are necessary for HOXA13 interaction; for MEIS1B, this domain was also sufficient. We also show by yeast two-hybrid assay that
MEIS proteins can interact with anterior HOX proteins, but for some, additional N-terminal MEIS sequences are required for interaction.
Using deletion mutants of HOXA13 and HOXD13, we provide evidence for multiple HOX peptide domains interacting with MEIS proteins.
These data suggest that HOX:MEIS interactions may extend to non-AbdB-like HOX proteins in solution and that differences may exist in the
MEIS peptide domains utilized by different HOX groups. Finally, the capability of multiple HOX domains to interact with MEIS C-terminal
sequences implies greater complexity of the HOX:MEIS protein–protein interactions and a larger role for variation of HOX amino-terminal
sequences in specificity of function.
D 2004 Elsevier Inc. All rights reserved.
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Hox genes encode a conserved set of transcription
factors that specify regional identity along the developing
anteroposterior axis of developing embryos. A common
feature of this gene family is that each protein has a 60-
amino-acid DNA-binding domain (DBD) referred to as the
homeodomain (HD) (Gehring et al., 1994). The mammalian
genome contains 39 Hox genes that reside in four separate
linkage groups, designated A to D, on four separate
chromosomes. Hox genes within each cluster can be0012-1606/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
doi:10.1016/j.ydbio.2004.10.004
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E-mail address: innis@umich.edu (J.W. Innis).categorized into 13 paralog groups based upon their
position and homology to the Drosophila Hox genes
(Krumlauf, 1994).
HOX specificity is acquired, in part, through cofactor
interaction (Mann and Affolter, 1998). The most studied
HOX cofactors are the vertebrate PBX and MEIS proteins,
two members of the TALE (Three Amino acid Loop
Extension) superclass of atypical homeodomain proteins
(Burglin, 1997). HOX proteins from paralog groups 1–10
form cooperative DNA-binding complexes with PBX
proteins, while those of groups 9–13, referred to as AbdB-
like, cooperatively bind DNA in vitro with MEIS1 proteins
(Chang et al., 1996; Shen et al., 1997a,b). In addition to
heterodimeric interactions on DNA with these TALE
superclass proteins, some HOX proteins have been shown277 (2005) 457–471
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MEIS or PREP1 proteins in the absence of DNA (Berthel-
sen et al., 1998; Jacobs et al., 1999; Shanmugam et al.,
1999; Shen et al., 1999).
Cooperative binding between anterior mammalian or
Drosophila HOX and PBX/Exd proteins, respectively, has
been shown to depend upon a highly conserved HOX
hexapeptide that lies N-terminal to the homeodomain (Chan
et al., 1994; Chang et al., 1995; Johnson et al., 1995; Ryoo
et al., 1999). The AbdB-like HOX proteins from paralog
groups 9 and 10 have a conserved tryptophan that mediates
PBX interaction (Chang et al., 1996; Shen et al., 1997b).
Importantly, HOX proteins from groups 11, 12, and 13 lack
a similarly positioned, conserved tryptophan, suggesting
that cofactor interaction may require other residues.
Cooperative interaction between MEIS1 and these AbdB-
like HOX proteins on DNA has been reported, but the
protein motifs mediating these interactions have not been
elucidated. The potential for interaction between MEIS and
more anterior HOX proteins without DNA binding has not
been tested.
There are a few reports describing coexpression
between MEIS and posterior HOX proteins; these have
been limited to the adult mouse epididymis, mouse ovary,
the developing limb bud, and myeloid cells (Bomgardner
et al., 2003; Lawrence et al., 1999; Mercader et al., 1999,
2000; Villaescusa et al., 2004). Complexes of HOX and
MEIS proteins have been recovered from myeloid cells
showing association of these proteins in an in vivo context
(Shen et al., 1999); however, the full extent of HOX:MEIS
associations and their importance in development is not
understood.
In the developing limb, the expression of Hox genes
from paralog group 13, Hoxa13 and Hoxd13, is restricted to
the distal autopod (Dolle et al., 1989; Haack and Gruss,
1993; Mortlock et al., 1996; Post and Innis, 1999).
However, Meis1 and Meis2 are restricted to proximal
regions of the developing limb (Mercader et al., 1999,
2000). Therefore in the distal limb bud, HOXA13 and
HOXD13 apparently function in the absence of MEIS1 and
MEIS2 proteins as potential cofactors. The expression
domain of Meis3 in the limb bud has not been reported.
This could imply that in the limb, HOX group 13 proteins
work as monomers (Galant et al., 2002) and/or that they
interact with other cofactors.
The present study was initiated to explore HOX:MEIS
interactions in more detail. We examined expression of
Meis and Hox paralog group 13 genes and encoded protein
products in the reproductive tract as one potential in vivo
site for HOX:MEIS interaction. Additionally, using a yeast
two-hybrid assay, we tested the range of AbdB and non-
AbdB-like HOX protein interactions with MEIS and the
capabilities of other TALE superclass proteins to interact
with HOXA13, and we probed the location of paralog
group 13 and MEIS peptide domains necessary for
interaction.Materials and methods
Whole-mount in situ hybridization
Embryos were collected from matings of C57Bl/6J mice
at E10.5 and E11.5. Embryos were staged by assigning
noon of the day of vaginal plug discovery as E0.5.
Antisense mRNA probes were transcribed as previously
described for Hoxa13 and Hoxd13 (Post and Innis, 1999).
A Meis3 antisense probe was created using a 531-bp
template consisting of contiguous coding sequence down-
stream of the homeodomain and 3V UTR. Following
linearization by AatII, an RNA probe was synthesized
using Sp6 RNA polymerase. Meis2 sense RNA probe was
created by NotI template linearization and transcription
using Sp6 RNA polymerase. Whole-mount in situ hybrid-
ization with a single digoxygenin-labeled RNA probe was
performed as previously described (Bober et al., 1994),
except BM purple (Roche) was used as the substrate for
alkaline phosphatase.
RT–PCR
Genital tracts were dissected frommale and female P1 (n =
5), and 10-week old female mice (n = 2). For each age, RNA
was prepared separately from the ovaries, uterus, and cervix/
vagina for the females and testis, epididymis, and prostate of
males, using Trizol (Invitrogen). All RT–PCRs were per-
formed using theOne-Step RT–PCRkit (Invitrogen) with 150
ng of total cellular RNA per 50-Al reaction. The RT step was
for 30min at 508C; the PCR used an annealing temperature of
568C and an extension time of 45 s at 728C for 40 cycles. PCR
primer pairs used, from 5V to 3V, forMeis1 (a and b),Meis2 (c
and d), and Meis3 (e and f) were (a) CGAGCAGTCAGC-
CAAGGGAC, (b) TCAGTCACCATTGTAGACAACG, (c),
GTGCAGCCCATGATTGACCAG, (d), TACTATTGGG-
CATGAATGTCC, (e) TTGAC-CAGTCTAATCGCACAG,
and (f)AGGGAGGTAGGCGTTGAATGG.Each primer pair
amplifies products spanning multiple exons, distinguishing
spliced mRNA from genomic DNA contamination. Gel
image analysis was done using the Quantity One software
with a Gel Doc 2000 (BioRad).
Immunohistochemistry
Antibodies to murine MEIS1 and HOXD13 were created
using the multiple antigenic peptide method (Posnett and
Tam, 1989), using amino acids 107–132 for MEIS1 and
176–198 for HOXD13. Anti-HOXA13 antibody, Ab490,
was previously described (Post et al., 2000). For section
immunohistochemistry, N-terminal MEIS1 and MEIS2
antibodies were obtained from Dr. A. Buchberg (Jefferson
Medical College, Philadelphia, PA). These two antibodies
were previously demonstrated to be specific for each protein
(Swift et al., 1998; Zhang et al., 2002). An antibody specific
for MEIS3 was not available at the time of this study.
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previously (Yokouchi et al., 1995) on dissected P1 female
genital tracts. Primary antibodies were used at dilutions of
1:10,000 for anti-MEIS1 and anti-HOXD13, and 1:5000 for
anti-HOXA13 and rabbit preimmune serum. The secondary
antibody, donkey anti-rabbit HRP conjugate (Amersham),
was used at a dilution of 1:500. For section immunohis-
tochemistry, reproductive tracts were dissected out of P1
mice, fixed with 4% paraformaldehyde for 1 h at room
temperature, and paraffin-embedded. Sections of 5Am were
used for analysis. Sections were dewaxed, rehydrated
through a series of graded ethanol concentrations, and
blocked overnight in PBST with 5% Carnation milk.
Samples were incubated at room temperature for 3 h with
primary antibodies at dilution of 1:1000 for anti-MEIS1,
anti-MEIS2, anti-HOXD13, rabbit preimmune serum, and
1:50 for affinity-purified anti-HOXA13. Sections were
incubated for 2 h with biotin-conjugated anti-rabbit secon-
dary antibody (Jackson Immunoresearch) at a dilution of
1:500. Vector Elite reagent was used according to manu-
facturer’s protocol (ABC, Vector Labs) to boost the signal.
Samples were developed with either DAB (Brown; Figs. 3J
and P) or Vector VIP (Purple; Vector Labs; Figs. 3E–I and
K–O) for 5–15 min to achieve desired color intensity.
Co-immunoprecipitation
NIH 3T3 cells were transfected with expression vectors
as indicated in Fig. 4. In brief, 550,000 cells were seeded in
6-cm dishes (three per condition) 18 h prior to transfection.
Following the transfection protocol for Lipofectamine Plus
(Invitrogen), each plate received 4 Ag of total DNA (2 Ag
per construct) with 16 Al of Plus reagent and 24 Al of
Lipofectamine. Forty-eight hours posttransfection, cell
lysates were prepared by collecting cells from three 6-cm
dishes by treatment with trypsin-EDTA. For each condition,
cells were pelleted by centrifugation, supernatant removed,
followed by addition of 1 ml cold lysis buffer (1% Triton X-
100, 0.1% SDS, 50 mM Tris-HCl pH 7.4, 150 mM NaCl, 1
mM EDTA), and mechanically disrupted with a 26-gauge
needle. Immunoprecipitation was performed using anti-
FLAG M2 affinity gel following manufacturer’s protocol
(Sigma). Eluted proteins were separated by electrophoresis
on 12% SDS-polyacrylamide gel. Proteins were transferred
to nitrocellulose for Western analysis using primary anti-
bodies at 1:10,000 (anti-HOXA13 and anti-MEIS1 107–
132) followed by donkey anti-rabbit HRP secondary anti-
body (Amersham) at 1:15,000, each in PBST with 5%
Carnation nonfat dry milk. Protein was visualized using
Supersignal chemilluminescent substrate (Pierce).
Yeast two-hybrid
All yeast two-hybrid preys were created by cloning
coding sequences into the vector pJG4-5 on the 3V end of the
B42 transcriptional activation domain (AD). Bait constructswere made by cloning coding sequences into the vectors
pEG202 or pEG202NLS (includes nuclear localization
signal) on the 3V end of the LexA DNA-binding domain
(DBD). All HOX and TALE superclass constructs were
derived from murine cDNAs. Control baits used were
pRFHMI (Bicoid HD) and pBait (TGFhRI). The bait
plasmid and lacZ reporter vector (pSH17-4) were trans-
formed into haploid yeast strain RFY206 (MATa), and preys
were transformed into the strain EGY48 (MATa) as
described previously (Gietz et al., 1992). Testing for bait
and prey interactions was accomplished by interaction
mating (Finley and Brent, 1994). After selecting for diploid
yeast, strains were transferred to media containing X-gal
with either glucose or galactose and grown overnight at
308C. Interaction readings were visually scored 24 h after
growth on X-gal-containing media.
Sequence analysis
Comparison of protein sequences was done using the
MEGALIGN program (DNASTAR) with the CLUSTALW
alignment algorithm (Thompson et al., 1994). A neighbor-
joining tree was generated in MEGALIGN, from the
CLUSTAL W sequence alignments. Accession numbers
for the Mus musculus protein sequences: HOXA13
(NP_032290), HOXB13 (NP_032293), HOXC13
(NP_034594), HOXD13 (NP_032301), MEIS1A
(Q60954), MEIS1B (NP_034919), MEIS2A (CAA04138),
MEIS2B (CAA04139), MEIS2C (CAA04140), MEIS2D
(CAA04141), MEIS3 (AAC52949), PREP1 (AAH52701),
PREP2 (AAM18702), TGIF (NP_033398), and PBX1A
(NP_899198). The accession number for Gallus gallus
HOXA13 proteins sequence is NP_989470.Results
Coexpression of HOXA13 and HOXD13 with MEIS proteins
in the female reproductive tract (FRT)
Meis1 and Meis2 are expressed in a separate proximal
limb region (data not shown) from that of Hoxa13 and
Hoxd13 (Figs. 1A and D) at early stages precluding
interaction (Mercader et al., 1999, 2000). By whole-mount
in situ hybridization on developing mouse embryos, we
analyzed the limb bud expression of Meis3 at E10.5 and
E11.5 (Figs. 1B and E). Similar to that of Meis1 and Meis2,
Meis3 is not expressed in the distal limb bud. Thus, lack of
Meis3 expression in the distal limb bud at these devel-
opmental time points excludes the possibility for a func-
tional interaction to occur between paralog group 13 HOX
and MEIS proteins.
Previous work demonstrated Meis2 expression in the
adult female reproductive tract henceforth referred to as
FRT (Oulad-Abdelghani et al., 1997); however, the precise
cell types were not delineated, and earlier developmental
Fig. 1. Expression patterns preclude a limb bud interaction between MEIS3 and either HOXA13 or HOXD13. Whole-mount in situ hybridization on E10.5 (B
and C), and E11.5 (A, and D–F) mouse embryos using antisense and sense RNA probes. Distal limb bud expression of (A) Hoxa13 and (D) Hoxd13. Meis3 is
expressed (B and E) in the somitic mesoderm, but not in the limb bud at these stages. Probe specificity is shown by the absence of any signal from embryos
incubated with a sense RNA probe (C and F).
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expression in the FRT is unknown. Hoxa13 is known to
be expressed in the mesenchymal region of the cervix/
vagina of both the developing and mature FRT (Ma et al.,
1998; Post and Innis, 1999; Taylor et al., 1997; Warot et al.,
1997). We define the developing FRT as the prepubertal
female reproductive tract immediately after birth (P1), a
time during peak morphological differentiation of the mouse
reproductive system (Podlasek et al., 2002; Taylor et al.,
1997). To determine whether Meis1, Meis2, and Meis3 are
also expressed in the developing and mature FRT, weFig. 2. Expression of Hoxa13, Meis1, Meis2, and Meis3 in both the developing
RNA was prepared from the testis, epididymis, and prostate of newborn (P1) mal
old (10 W) female mice, and used for RT–PCR. Primers distinguish the splice vari
differences.performed RT–PCR using RNA collected from the ovary,
uterus, and cervix/vagina regions of P1 and 10-week-old (10
W) females. Consistent with previous results (Taylor et al.,
1997), Hoxa13 expression was detected only in RNA
derived from the cervix/vagina tissue of the mature FRT,
whereas expression was also detected in the ovary and
uterus in addition to the cervix/vagina in the developing
FRT, albeit at lower levels (Fig. 2). Each Meis2 splice
variant (Meis2a–d) was expressed in the ovary, uterus, and
cervix/vagina RNA at nearly equivalent levels. The two
Meis1 splice variants (Meis1a and Meis1b) are expressed inmale and female and the mature female reproductive tracts. Total cellular
e mice and ovary, uterus, and cervix/vagina of both newborn and 10-week-
ants of Meis1 (Meis1a and Meis1b) and Meis2 (Meis2a–d) based upon size
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expression consistently appeared greater than that of Meis1a
(similar trend seen in the developing male reproductive
tract). As seen forMeis1 andMeis2,Meis3 is also expressed
in each of the RNA populations. Unlike Hoxa13 where
expression differences exist between the developing and
mature FRT, no differences were observed for Meis1–3.
Hoxa13, Hoxd13, and Hoxb13 are expressed in the male
reproductive tract (Economides and Capecchi, 2003; Pod-
lasek et al., 2002). To determine whether Meis1-3 is also
expressed within the same tissues as Hoxa13, RT–PCR was
performed using RNA derived from the testis, epididymis,
and prostate of P1 male mice. Similar to the expression in
the FRT, Meis1, Meis2, and Meis3 are expressed in each of
the tested RNA populations (Fig. 2). P1 expression of
Hoxa13 is detected in the prostate as well as in both the
epididymis and testis. Expression of Hoxd13 was also
detected in prostate RNA and weakly in that of the
epididymis and testis (data not shown). These experiments
broadly define the male and female reproductive tracts as
tissues where Hoxa13 and Meis1-3 are coexpressed.Fig. 3. Expression of HOXA13, HOXD13, MEIS1, and MEIS2 in the developing
shows strong HOXA13 (A), and HOXD13 (B) expression detected in the caudal
rostral structures of the uterus and ovaries. MEIS1 expression (C) is obse
immunohistochemistry (E–J at 100; K–P at 400) shows expression of HOXA13
O) in cell types within the developing cervix and vagina. Preimmune control is
expression (F) is detected in both the cervix (Cx) and vagina (Va). Cell type-sp
magnification (K–P). For HOXA13, expression is limited to the mesenchymal cell
The expression pattern of HOXD13 is similar to that of HOXA13, with expressio
cells (M and P). The mesenchyme-restricted expression of HOXD13 is better vis
throughout both the cervix and vagina (H and I), and expression is nuclear in both To determine whether HOXA13 and HOXD13 are
coexpressed within the same regions and cells as MEIS
proteins, we performed immunostaining on developing FRTs
(Fig. 3). Consistent with the RT–PCR data, by whole-mount
immunostaining, HOXA13 expression appears highest in the
caudal regions of the developing FRT (Fig. 3A), which
includes the cervix and vagina. This restricted expression
pattern was also observed for HOXD13 (Fig. 3B). Using an
antibody that recognizes both MEIS1A and MEIS1B,
expression was found to extend throughout the entire FRT
(Fig. 3C). To further demonstrate which cell types within the
developing cervix and vagina are expressing HOXA13,
HOXD13, MEIS1, and MEIS2 and whether expression
occurs in the same or separate cell populations, immunohis-
tochemistry was performed on histological sections from P1
females (Figs. 3E–P). The available antibodies were all
raised in the same species making double-labeling experi-
ments to demonstrate cellular coexpression impractical.
HOXA13 expression was shown to extend throughout the
mesenchyme (MES) of the cervix and vagina (Fig. 3F) but
not that of the stratified squamous epithelium (SSE, Fig. 3L).female reproductive tract. Whole-mount immunostaining of newborn FRTs
cervix and vagina region, while expression is faintly observed in the more
rved throughout the ovary, uterus, and cervix/vagina region. Section
(F and L), HOXD13 (G, J, M, and P), MEIS1 (H and N), and MEIS2 (I and
shown to demonstrate antibody specificity (E and K). Nuclear HOXA13
ecific expression, area indicated by red box (E), can be seen at a higher
s (MES), and not cells in the stratified squamous epithelial (SSE) layer (L).
n in both the cervix and vagina (G and J), and limited to the mesenchymal
ualized using DAB as the substrate (P). MEIS1 and MEIS2 are expressed
MES and SSE cells (N and O). 
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of the vagina (Va) and cervix (Cx). However, HOXD13
expression does not extend as far rostral into the cervix (Figs.
3G and J). HOXD13 expression is restricted to the MES
(Figs. 3M and P). Expression of both MEIS1 and MEIS2
extends throughout the cervix and vagina (Figs. 3H and I) in
both the mesenchyme and stratified squamous epithelial
layers (Figs. 3N and O). HOXA13, HOXD13, MEIS1, and
MEIS2 are predominantly nuclearly localized; this was
confirmed by sections stained with the nuclear tropic dye,
hematoxylin (data not shown). This is the earliest and most
thorough demonstration of MEIS expression in the FRT.
These results demonstrate that within the cervix and vagina
of the developing FRT, paralog group 13 HOX proteins are
coexpressed in the nuclei of mesenchymal cells with MEIS
proteins, presenting an opportunity for functional interac-
tions to occur.
MEIS1B interacts with HOXA13 in mammalian cells
MEIS1A and MEIS1B have been shown to interact with
HOX proteins in triple complexes as non-DNA-binding
partners (Shanmugam et al., 1999; Shen et al., 1999), and
MEIS1A/HOXA9 complexes can form in the absence of
DNA (Shen et al., 1997b). To test whether HOXA13 and
MEIS1B could be recovered as a complex from cervix/
vagina cells, co-immunoprecipitation was attempted using
cellular extracts from P1 FRT preparations. Unfortunately,
all available antibodies were created in rabbits. This
precluded the clear visualization of proteins of interest by
Western analysis (data not shown).
We thus elected to perform co-immunoprecipitation
using lysates generated from NIH 3T3 cells transfected
with C-terminal FLAG-tagged full-length HOXA13 and N-
terminal Myc-tagged full-length MEIS1B (Fig. 4). Using an
anti-FLAG agarose conjugate, HOXA13-FLAG was immu-
noprecipitated from lysates. MEIS1B was recovered after
immunoprecipitating HOXA13-FLAG (Fig. 4, lane 4), butFig. 4. HOXA13 and MEIS1B interact in mammalian cells. Co-immunoprecipita
Myc-MEIS1B was expressed in NIH 3T3 cells with or without HOXA13-FLAG. W
an anti-FLAG agarose conjugate. Cell lysates (lanes 1–3) and proteins eluted fr
subjected to Western blotting separately with anti-HOXA13 and anti-MEIS1 antib
Myc-MEIS1B expression constructs, lanes 2 and 5 from cells transfected with Myc
empty vector.not from lysates without HOXA13-FLAG (Fig. 4, lane 5).
Similar results were obtained using HOXD13-FLAG (data
not shown). These results indicate that group 13 HOX
proteins can be recovered from mammalian cells in a soluble
complex with MEIS1B.
MEIS1A and MEIS1B interact specifically with HOXA13
To further characterize direct HOXA13-MEIS1 peptide
interactions, we used a yeast two-hybrid system (Gyuris et
al., 1993). The full-length coding sequences for Meis1a and
Meis1b (amino acids 1–390 and 1–465, respectively) were
cloned in-frame on the 3V end of the B42 AD (Activation
Domain), placing MEIS1 peptide sequences at the carboxy-
terminus of expressed prey molecules. Baits were created
that divided the complete HOXA13 coding sequence into
three overlapping segments (Figs. 5A and B5–7), each
cloned on the 3V end of the LexA DBD (DNA-binding
domain). An interaction with MEIS1B was observed with
the bait containing the coding sequence for amino acids
150–313 of HOXA13, but not with those for HOXA13
amino acids 1–165 or 283–386 (Fig. 5C, baits 5–7).
Identical results were observed with MEIS1A (data not
shown). Since the prey protein is only expressed on plates
containing galactose, by the GAL1 promoter, the lacZ
expression can be concluded to result from the interaction
between either MEIS1A or MEIS1B and the 150–313
HOXA13 bait and not from autoactivation of the reporter by
the bait protein alone, as seen for the LexA DBD-Gal4 AD-
positive control (Fig. 5C, bait 2). The specificity of this
interaction was verified by demonstrating that MEIS1A and
MEIS1B preys do not interact with either the LexA DBD
bait alone, the LexA DBD fused with the Bicoid HD, or the
LexA DBD fused with the TGFhRI (Fig. 5C, baits 1, 3, and
4). In addition, the bait containing amino acids 150–313 of
HOXA13 did not interact with the B42 AD only, confirming
that the interaction is between HOXA13 and MEIS1B and
not the adjacent heterologous activation domain. As a finaltion demonstrates an in vivo interaction between MEIS1B and HOXA13.
hole cell lysates were prepared and subjected to immunoprecipitation using
om the agarose conjugate (lanes 4–6) were resolved by SDS–PAGE and
odies. Lanes 1 and 4 are from cells transfected with HOXA13-FLAG and
-MEIS1B and empty expression vector, and lanes 3 and 6 received only the
Fig. 5. Amino acids 150–313 of HOXA13 specifically interacts with MEIS1B in yeast. (A) Diagram of full-length HOXA13 (1–386) with three polyalanine
tracts (red) and C-terminal homeodomain (dark blue). HOXA13 was subdivided into three overlapping yeast two-hybrid baits; amino acids 1–165, 150–313,
and 283–386. (B) Baits tested for interaction with MEIS1B; (1) LexA DNA-binding domain (DBD) only, (2) LexA DBD + Gal4 activation domain (AD), (3)
LexA DBD + Bicoid homeodomain (HD), (4) LexA DBD + TGFhRI, (5) LexA DBD + HOXA13 1–165, (6) LexA DBD + HOXA13 150–313, and (7) LexA
DBD + HOXA13 283–386. (C) Results for the interaction assay for each bait with the B4 AD only prey or B42 AD with full-length MEIS1B. The prey protein
is only expressed on media containing galactose. 
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MEIS1A and MEIS1B the bait and HOXA13 150–313 the
prey. Here, a strong interaction between HOXA13 and both
MEIS1A and MEIS1B was observed (data not shown).
MEIS1A and MEIS1B interact specifically with other HOX
proteins
To determine whether all paralog group 13 Hox proteins
could interact with MEIS1A and MEIS1B, the protein
sequences encoded by the entire first exons of Hoxb13,
Hoxc13, and Hoxd13 were cloned into the pJG4-5 prey
vector, and the expressed preys were tested for interaction
with both full-length MEIS1A and MEIS1B baits. A specific
interaction of comparable intensity to that of HOXA13 was
seen for each paralog group 13 member (Table 1). First exon
encoded protein sequences of HOXA13 were also sufficient
for interaction (see Fig. 7A). Of interest, full-length HOX
proteins (HOXD13, HOXA11, HOXA9) failed to interact
with either MEIS1A or MEIS1B (data not shown). How-
ever, deletion of 27 amino acids from the carboxy-terminus
of full-length HOXD13 (using only aa 1–312) or conversion
of the homeodomain residues I47Q50N51 to alanines (Car-
onia et al., 2003), which severely reduces DNA binding,
allowed interaction.
We then tested whether other HOX proteins could
interact with MEIS1 proteins. The entire first exon encoded
proteins for the AbdB-like genes Hoxd12, Hoxa11, Hoxa10,Hoxa9, and the non-AbdB-like genes Hoxb8, Hoxa5,
Hoxb4, and Hoxa2 were cloned into the pJG4-5 prey
vector. None of these contained their homeodomain. A
reproducible interaction was demonstrated between each of
the expressed HOX preys and both full-length MEIS1A and
MEIS1B baits (Table 1). The interactions were shown to be
specific, in that no interaction was observed between any of
the HOX preys and the control baits including the LexA
DBD alone, or LexA DBD with either the Bicoid HD or
TGFhRI. The results demonstrate that in the context of
eukaryotic yeast nuclei, MEIS1A and MEIS1B interact with
representative members of anterior, non-AbdB-like HOX
proteins (paralog groups 2, 4, 5, and 8) as well as posterior,
AbdB-like HOX proteins (paralog groups 9–13). Although
previous studies demonstrated the inability for cooperative
DNA-binding interactions to occur between MEIS1 proteins
and the anterior HOX proteins (Shen et al., 1997a), those
findings do not preclude an interaction in solution, which
could affect the concentration of free and bound HOX and
MEIS transcription factors in cells.
Paralog group 13 HOX proteins do not interact with other
TALE superclass members
MEIS1 belongs to the TALE superclass of homeodomain
proteins (Burglin, 1997). We sought to determine whether
other members of this group could interact with HOXA13.
We amplified the full-length coding sequences for Meis2b,
Table 2B
MEIS3, in prey configuration, interacts specifically with HOXA13
Prey LexA DNA-binding domain baits
Empty GAl4 ADa Bicoid HD TGFhRI HOXA13
Empty 0 +++ 0 0 0
MEIS3 0 +++ 0 0 +++
0, no interaction detected by lacZ activity.
+++, strong interaction detected by lacZ activity.
, not tested for interaction.
a Gal4AD is a positive control for lacZ activity.
Table 1
Full-length MEIS1A and 1B interact with HOX proteins of most paralog
classes
Preys LexA DNA-binding domain baits
Empty Gal4ADa Bicoid
HD
TGFhR1 MEIS1A/
1B
Emptyb 0 +++ 0 0 0
HOXA13
(150–313)
0 +++ 0 0 +++
HOXB13
(1–200)
0 +++ 0 0 +++
HOXC13
(1–243)
0 +++ 0 0 +++
HOXD13
(1–256)
0 +++ 0 0 +++
HOXD12
(1–200)
0 +++ 0 0 +++
HOXA11
(1–236)
0 +++ 0 0 ++
HOXA10
(1–308)
0 +++ 0 0 +
HOXA9
(1–192)
0 +++ 0 0 +++
HOXB8
(1–142)
0 +++ 0 0 +++
HOXA5
(1–187)
0 +++ 0 0 +++
HOXB4
(1–151)
0 +++ 0 0 +++
HOXA2
(1–126)
0 +++ 0 0 ++
0, no interaction detected by lacZ activity.
+++, strong interaction detected by lacZ activity.
++, medium interaction detected by lacZ activity.
+, minor interaction detected by lacZ activity.
a Gal4AD is a positive control for lacZ activity.
b Prey protein is the B42 AD alone.
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were cloned 3V of the LexA DBD and tested for interaction
in yeast with the HOXA13 prey (amino acids 150–313).
MEIS2B interacted with the HOXA13 prey, while those of
PREP1, PREP2, and TGIF did not (Table 2A). As the bait,
MEIS3 was a strong transcriptional activator in the absence
of an expressed prey protein. To circumvent this autoacti-
vation, Meis3 was cloned into the prey vector, and the
expressed prey was shown to interact with the HOXA13
150–313 bait (Table 2B). Preys containing the C-terminalTable 2A
HOXA13 peptide (150–313) interacts with MEIS proteins
Preys LexA DNA-binding domain baits
MEIS1A MEIS1B MEIS2B
Emptya 0 0 0
HOXA13 (1–165) 0 0 0
HOXA13 (150–313) +++ +++ +++
HOXA13 (283–386) 0 0 0
0, no interaction detected by lacZ activity.
+++, strong interaction detected by lacZ activity.
, not tested for interaction.
a Prey protein is the B42 AD alone.127 amino acids of MEIS2C and MEIS2D, which do not
include any portion of their homeodomains, also interacted
with the HOXA13 150–313 bait (data not shown). To test
for additional N-terminal or C-terminal HOX residues
required for TALE superclass interactions, we tested preys
that contained the protein sequences for HOXD13 1–212
and HOXA13 150–360 (data not shown). No interaction
occurred with either PREP1 or PREP2; however, we cannot
rule out that other domains of HOXA13 or HOXD13 as full-
length molecules interact with more diverged TALE
members. These results demonstrate that MEIS2 and MEIS3
proteins, in addition to MEIS1, have the capacity to interact
with HOXA13. Interaction of TALE superclass members
with group 13 HOX proteins appears to be restricted to the
MEIS proteins and not with closely related PREP1 and
PREP2 proteins or the more distantly related TGIF
(Fig. 6A).
The C-termini of MEIS1A and MEIS1B mediate interaction
with HOXA13
To localize the HOXA13-interacting peptide domains of
MEIS1A and MEIS1B, we created various yeast two-hybrid
preys by subdividing these proteins and determining their
ability to interact in yeast (Fig. 6B). Interaction with the
HOXA13 150–360 bait was observed with full-length
MEIS1B (1–465) as well as N-terminal deleted MEIS1B
preys comprising amino acids 214–465 or 358–465. A
MEIS1B prey composed of amino acids 369–465 was also
sufficient for interaction. C-terminal MEIS1-deleted preys
comprising amino acids 1–329 or 214–346 failed to interact
with the HOXA13 bait. In-frame deletion of the region
between the homeodomain and the C-terminal region ofMEIS3 PREP1 PREP2 TGIF
+++ 0 0 0
+++   
+++ 0 0 0
+++   
Fig. 6. MEIS proteins interact with HOXA13 through their C-terminal domain. (A) Neighbor joining tree based on amino acid sequence identity for selected
TALE superclass members. TALE proteins which where demonstrated to interact with HOXA13 amino acids 150–313 are shown in red, those that did not
interact in blue, and not tested in black. (B) Diagrammatic representation of MEIS1 preys tested for interaction with the HOXA13 150–360 bait, and their
interaction status. The MEIS homeodomain (HD) is in yellow, and unique C-terminal domains (CTD) of MEIS1A and MEIS1B are colored in red and light
blue, respectively. Dashed line represents an in-frame deletion of protein sequence. 
T.M. Williams et al. / Developmental Biology 277 (2005) 457–471 465MEIS1B (MEIS1B D330–372), which is identical in
MEIS1A, also strongly interacted with the HOXA13 bait.
Together, these data demonstrate that within the unique C-
terminal domain (CTD) of MEIS1B resides the motif(s)
responsible for interaction with HOXA13. It was thus
surprising that full-length MEIS1A (1–390) also interacts
with the HOXA13 150–360 bait. The 18-amino-acid CTD
of MEIS1A (373–390) alone failed to interact with the
HOXA13 bait (data not shown), perhaps due to the small
size of the prey molecule. However, the necessity of the C-
terminal 18 amino acids was demonstrated using MEIS1A
preys with in-frame deletions of amino acids 274–329
(removes the homeodomain) and 274–372 (removes the
homeodomain and adjacent C-terminal identical sequences).
These preys both were able to interact with the HOXA13bait. Collectively, these results demonstrate that the C-
terminal peptide domains (CTD) of MEIS1A and MEIS1B
are necessary for interaction with HOXA13. Moreover, the
CTD of MEIS1B was shown here to be sufficient for
interaction.
Differences in MEIS1B peptide sufficiency for HOX
interaction
To determine the MEIS1B peptide sufficiency for addi-
tional HOX interactions, MEIS1B baits consisting of amino
acids 1–465 (full length) and 340–465 (C-terminal 126
amino acids) were tested for interaction with various HOX
preys (Table 3). Two different patterns of interaction were
observed. First exon encoded peptide sequences of HOXB8,
Table 3
Differences in MEIS1 sufficiency for HOX interaction in yeast
Preys LexA DNA-binding domain baits
Empty Gal4ADa Bicoid HD TGFhR1 MEIS1 (1–465) MEIS1B (340–465)
Emptyb 0 +++ 0 0 0 0
HOXA13 (150–313) +/ +++ +/ 0 +++ +++
HOXB13 (1–200) 0 +++ 0 0 +++ +++
HOXC13 (1–243) +/ +++ +/ 0 +++ +++
HOXD13 (1–256) 0 +++ 0 0 +++ +++
HOXD12 (1–200) 0 +++ 0 0 +++ +++
HOXA11 (1–236) 0 +++ 0 0 ++ 0
HOXA10 (1–308) 0 +++ 0 0 + 0
HOXA9 (1–192) 0 +++ 0 0 +++ +++
HOXB8 (1–142) +/ +++ +/ 0 +++ +++
HOXA5 (1–187) 0 +++ 0 0 +++ 0
HOXB4 (1–151) 0 +++ 0 0 +++ 0
HOXA2 (1–126) 0 +++ 0 0 ++ 0
0, no interaction detected by lacZ activity.
+++, strong interaction detected by lacZ activity.
++, medium interaction detected by lacZ activity.
+, minor interaction detected by lacZ activity.
+/, varies between no lacZ activity to minor lacZ activity in replication.
a Gal4AD is a positive control for lacZ activity.
b Prey protein is the B42 AD alone.
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interacted with both MEIS1B baits. First exon encoded
peptide sequences of HOXA2, HOXB4, HOXA5,
HOXA10, and HOXA11 could interact with the full-length
MEIS1B, but not with the C-terminal 126 amino acids. The
HOXA10 and HOXA11 preys interacted with a MEIS1B
bait including amino acids 214–465 (albeit attenuated, data
not shown). Thus, within the AbdB-like group of HOX
proteins, HOXA10 and HOXA11 appear to require addi-
tional MEIS1B sequence for interaction. These experiments
demonstrate differences in MEIS peptide sufficiency for the
broad repertoire of possible HOX:MEIS associations.
HOXA13 has multiple MEIS interaction domains
To identify HOXA13 residues critical for MEIS inter-
action, we created a series of nested, smaller HOXA13
preys and tested them for their ability to interact with full-
length MEIS1A and MEIS1B baits (Fig. 7A). A HOXA13
prey consisting of amino acids 150–360 interacts with both
MEIS1A and MEIS1B. N-terminal deletions of this
construct to residue 237 did not disrupt interaction with
MEIS1A or MEIS1B, yet a protein truncated to residue 247
was unable to interact with either MEIS1A or MEIS1B.
Progressive C-terminal deletions of the HOX 150–360 prey,
as far as residue 250, were also able to interact with
MEIS1A and MEIS1B. However, further C-terminal dele-
tions to amino acid 246 or to 242 abrogated interaction. The
shared sequence in all MEIS-interacting HOXA13 preys is
amino acids 237–250 (Fig. 7C, domain II). Comparison of
amino acid sequences for all murine paralog group 13 HOX
proteins and chicken HOXA13 shows that residues Y, Q, Y
(uncharged polar side chains), and D (charged polar sidechain) are conserved. To test whether this region is
necessary for MEIS interaction, a prey with an in-frame
deletion of these amino acids was created. This prey, A13
150–313 (D237–250), robustly interacts with both MEIS1A
and MEIS1B. Taken together, the data suggested that more
than one domain for MEIS interaction exist within amino
acids 150–313 of HOXA13. However, one domain appears
to be within the conserved region defined by HOXA13
amino acids 237–250.
Multiple MEIS interaction domains in HOXD13
To determine whether HOXD13 also contains multiple
domains capable of mediating MEIS interaction, a series of
HOXD13 mutant preys were created. A prey containing
amino acids 1–312 strongly interacts with MEIS1A and
MEIS1B (Fig. 7B). This prey, like HOXA13 150–360,
terminates at amino acid 312 just before helix 3/4 of the
homeodomain. C-terminal truncations as far as residue 139
of HOXD13 retained interaction with MEIS1A and
MEIS1B. Further deletion to residue 118 eliminated
interaction. Conversely, an N-terminal truncation to residue
139, construct 139–312, was able to interact with both
MEIS1A and MEIS1B, although it shares only one amino
acid with the minimal N-terminal interacting prey (1–139).
Within the region between amino acids 118 and 139 resides
a domain with high sequence identity among all murine
group 13 paralogs and chicken HOXA13 (Fig. 7C, domain
I). An in-frame deletion of domain I (D123–135) in the
construct 1–180 eliminates interaction with MEIS1A and
MEIS1B [compare D13 1–180 (D123–135) to D13 1–180].
Addition of further C-terminal sequences to this clone
restored interaction in the absence of domain I [D13 1–256
Fig. 7. HOXA13 and HOXD13 have multiple MEIS interaction domains. Diagrammatic representation of various (A) HOXA13 and (B) HOXD13 preys tested
for interaction with MEIS1A and MEIS1B. The MEIS-interacting preys are indicated in black and noninteracting preys in red. In-frame deletion of amino acid
residues is indicated by a horizontal dashed line. (C) Sequence alignment of mouse HOXD13 amino acids 123–135 (domain I) and HOXA13 amino acids 237–
250 (domain II) with mouse paralog group 13 HOX proteins and chicken HOXA13. In red are residues conserved among all compared proteins.
T.M. Williams et al. / Developmental Biology 277 (2005) 457–471 467(D123–135)]. Thus, HOXD13, like HOXA13, is capable of
interacting with MEIS1A and MEIS1B through multiple
domains.Discussion
Paralog group 13 HOX proteins function with or without
MEIS protein cofactors
In the developing limb bud, the paralog group 13 HOX
proteins, HOXA13 and HOXD13, play an essential role in
the proper patterning and development of the distal autopod
(Fromental-Ramain et al., 1996). However, during develop-
ment, the expression of Meis1 and Meis2 is restricted to aseparate proximal region (Mercader et al., 1999, 2000).
Here, we show that like Meis1 and Meis2, Meis3 is not
expressed in the distal limb bud. This suggests that
HOXA13 and HOXD13 contribute to early limb develop-
ment in a MEIS-independent manner and either function as
monomers or utilize other cofactors. Whether later stages or
selected cells within the developing limb utilize group 13
HOX:MEIS complexes remains to be explored.
Outside of the limb, Hoxa13 is expressed, among other
places, in both the developing male and female reproductive
tract as well as the mature female reproductive tract and is
essential for their proper development (Ma et al., 1998;
Podlasek et al., 2002; Post and Innis, 1999; Taylor et al.,
1997; Warot et al., 1997). While Meis2 is known to be
expressed in the adult FRT (Oulad-Abdelghani et al., 1997),
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FRT and that HOXA13, HOXD13, MEIS1, and MEIS2
proteins are coexpressed in the nuclei of mesenchymal cells
in the cervix and vagina. This work indicates that the
developing reproductive tract presents a context where
group 13 HOX proteins may have functional interactions
with MEIS cofactors. It is notable that proximal limb
expression of group 11 and 13 HOX proteins downregulate
the expression of MEIS and that distal expression of MEIS
downregulates group 13 HOX expression (Capdevila et al.,
1999; Mercader et al., 1999). Here, we demonstrate that this
mutually exclusive expression is not observed in the
reproductive tract. Whether these proteins actually associate
in the reproductive tract must now be explored.
Range of HOX:MEIS interactions
In vitro experiments have demonstrated that representa-
tive members from each AbdB-like HOX paralog group (9–
13) can cooperatively bind DNA with MEIS1. In this same
experimental context, MEIS1 was unable to cooperatively
bind DNAwith more anterior HOX proteins (paralog groups
1–8) (Shen et al., 1997a). It should be pointed out that the
yeast two-hybrid system has been used successfully several
times to study HOX protein interactions (Chan et al., 1994,
1995; Johnson et al., 1995). Utilizing a yeast two-hybrid
system to monitor protein–protein interaction, we showed
all paralog group 13 HOX proteins, HOXD12, HOXA11,
HOXA10, and HOXA9 can interact with MEIS1A and
MEIS1B. Importantly, we also observed interactions
between MEIS1A and MEIS1B with the anterior, non-
AbdB-like HOX proteins, HOXA2, HOXB4, HOXA5, and
HOXB8. Taken together, this suggests that association of
these factors can occur not only between DNA-bound
AbdB-like HOX proteins and MEIS, but also in solution
where neither component or only one may be bound to
DNA. These interactions may not have been observed in
prior studies using proteins of paralog groups 4, 6, 7, and 8
as the methods were evaluating only DNA-bound com-
plexes, which places a different requirement on the physical
association (Shen et al., 1997a). Extensive, thorough work
by that group with DNA site selection assays, using HOXB7
and MEIS1B, only identified single HOX or MEIS binding
sites. Since we did not test groups 6 and 7 proteins for
interaction, we cannot rule out the possibility that MEIS
interactions are discontinuous among all HOX proteins. Our
assay is potentially more sensitive, yet it was specific.
Selective interactions of HOXA13 and TALE superclass
proteins
MEIS proteins belong to a class of atypical homeo-
domain proteins known as the TALE superclass (Burglin,
1997). Within this group of related proteins, interactions
with HOX proteins have been demonstrated for PBX and
MEIS proteins, and a third member, PREP1, that interactswith PBX already complexed with a HOX protein (Mann
and Affolter, 1998). Here, we demonstrated that TALE
superclass proteins that are capable of interacting with
HOXA13 include not only MEIS1A and MEIS1B, but also
MEIS2A, MEIS2C, MEIS2D, and MEIS3. More diverged
family members PREP1, PREP2, and TGIF were unable to
interact in this assay. The possible range of interactions
demonstrated here would be expected to have broad in
vivo relevance, particularly in tissues that express multiple
MEIS isoforms as we have demonstrated for the repro-
ductive tract.
Peptide domains contributing to interactions between HOX
and MEIS proteins
HOX proteins from paralog groups 1–8 and PBX
proteins interact through a HOX hexapeptide, while those
of paralog groups 9 and 10 utilize a conserved ANW
peptide motif, each N-terminal to the HOX homeodomain
(Mann and Chan, 1996; Shen et al., 1997b). Interaction
through the hexapeptide motif has been demonstrated to
affect in vitro cooperative DNA-binding and in vivo
functionality (Chang et al., 1995; Medina-Martinez and
Ramirez-Solis, 2003; Shen et al., 1997b). The tryptophan
residue (W) of HOXA9 is not necessary for cooperative
DNA binding with MEIS1B (Shen et al., 1997b), thus
suggesting different sequence requirements for interaction.
In our study, we demonstrated for all tested HOX proteins
that MEIS-interacting motifs are within the peptide sequen-
ces encoded by the first exons, thus excluding homeodo-
main sequences. We also showed that multiple domains are
capable of mediating interaction with MEIS1A and
MEIS1B.
Domain I has high amino acid identity among all paralog
group 13 HOX proteins and is conserved in the Drosophila
AbdB protein (Mortlock et al., 2000). Pinpointing the
interaction motifs beyond domain I remains to be done and
may be challenging as sequence conservation outside of the
homeodomain is remote among HOX proteins of different
paralog groups. Another domain appears to be represented
by HOXA13 amino acids 237–250, here referred to as
domain II. Within this domain, four residues (YQYD) are
completely conserved between paralog group 13 HOX
proteins. Other AbdB-like HOX proteins appear to lack
strict conservation of the sequences comparable to domains
I and II. However, review of several HOX protein sequences
from paralog groups 9–12 reveals the existence of several
tyrosine-rich segments. Whether these sequences mediate
interaction with MEIS1 would need to be systematically
tested to understand the generality of multiple MEIS
interaction domains.
Within MEIS proteins, we demonstrate that the HOXA13
interacting region lies within the unique C-termini of
MEIS1A and MEIS1B. Remarkably, the C-terminal
HOXA13-interacting domain of MEIS1A is only 18 amino
acids and has limited sequence identity with the C-terminal
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residues are required for HOXA13 interaction or that
altogether unique peptides mediate binding. While the C-
terminal domain of MEIS1B is shown here to be sufficient
for interaction with all group 13 HOX proteins and with
HOXD12, HOXA9, and HOXB8, the C-terminal domain of
MEIS1B was not sufficient to interact with HOXA2,
HOXB4, HOXA5, HOXA10, and HOXA11; interaction
with these proteins requires the contribution of additional N-
terminal MEIS peptide sequences. Unique functional out-
comes may result from different HOX:MEIS complexes.
Multiple interaction domains and range of HOX:MEIS
interactions
Based on previous work with the hexapeptide motif, we
anticipated that we would identify a single HOX peptide
motif mediating interaction with MEIS proteins. However,
recent studies have revealed cooperative in vitro DNA
binding between Exd and AbdA or Ubx, even when the
HOX hexapeptide is mutated (Galant et al., 2002; Merabet
et al., 2003). The AbdA hexapeptide mutant maintains the
ability to transform segment identity in vivo in an Exd-
dependent manner. Additionally, the first report document-
ing cooperative interactions between Ubx and Exd was
performed using a Ubx variant lacking the hexapeptide
motif (Chan et al., 1994). These results cumulatively shed
light on our observation, relative to HOX:MEIS interaction,
in pointing to additional residues besides the hexapeptide
that may promote physical interaction with the Exd cofactor.
Of great mechanistic importance, the AbdA hexapeptide
mutant retained normal in vivo binding site selection;
however, on one target, the mutant protein changed from
a repressor to an activator (Merabet et al., 2003). This
suggests the possibility that utilization of different cofactor
interaction motifs may alter the transregulatory properties of
the HOX protein in a target gene-specific manner. Our
studies point to the capability of multiple, separate domains
of HOXA13 and HOXD13 and possibly for additional HOX
proteins for MEIS interaction. Another interpretation of our
data is that these proteins are interacting nonspecifically in
yeast two-hybrid, which might also explain the data with the
anterior HOX proteins. However, we believe that the
demonstrated restriction of TALE superclass interactions,
variable requirement for N-terminal MEIS peptide sequen-
ces for interaction with HOX proteins, and absence of an
interaction for numerous baits and preys argue for specific-
ity in our experimental results. Future studies are needed to
identify the full complement of interaction motifs and
determine their contribution to cooperative DNA binding
and in vivo transregulatory function.
It is well established that a major mode of HOX function
occurs through the regulation of target genes via direct DNA
binding with or without cofactors. However, many studies
have revealed functions for homeodomain proteins, inclu-
ding HOX, where the homeodomain is unable to bind DNAas a monomer or is devoid of the DNA-binding domain
altogether (Ananthan et al., 1993; Caronia et al., 2003; Chen
et al., 2004; Copeland et al., 1996; Fitzpatrick et al., 1992;
Suzuki et al., 2003; Zappavigna et al., 1994). Thus, we
hypothesize that biologically meaningful HOX:MEIS inter-
actions may not be confined to only those on DNA. Future
studies to understand HOX function should include the
possibility that HOX proteins exert functional effects
through protein–protein interactions where the HOX protein
is either a non-DNA-binding partner or is interacting in
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